2005 (32 POSTS)
Teeguarden JG, Waechter JM Jr, Clewell HJ 3rd, Covington TR , Barton HA. 2005. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicol Sci 85:429–446.
View Abstract
Publication: Manuscripts
Staskal DF , Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 84(2):225-31; doi: 10.1093/toxsci/kfi090 .
View Abstract
Publication: Manuscripts
Staskal DF , Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Toxicokinetics of BDE 47 in female mice: Effects of dose, route of exposure, and time. Toxicol Sci. 83(2):215-23; doi: 10.1093/toxsci/kfi018 .
View Abstract
Publication: Manuscripts
Urban JD , Mailman RB. Characterization of the N27 dopaminergic cell line as a model for elucidating the actions of functionally selective dopaminergic ligands. 35th Annual Neuroscience Meeting, Washington, DC, November 2005.
Publication: Abstracts and Presentations
Grasty RC , Roberts N, Klinefelter G, Bjork JA, Wallace KB, Lau CS, Rogers JM . 2005. Effects of prenatal perfluorooctanesulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res A 73: 314.
Publication: Abstracts and Presentations
2004 (20 POSTS)
Thompson CM , Wojno H, Greiner E, May EL, Rice KC, Selley DE. 2004. Activation of G-proteins by morphine and codeine congeners: Insights to the relevance of O- and N-demethylated metabolites at μ- and δ-opioid receptors. J Pharmacol Exper Therapeut 308(2):547–554; PMID: 14600248 .
View Abstract
Publication: Manuscripts
Warren DA, Kerger BD, Britt JK , James RC. 2004. Development of an oral cancer slope factor for Aroclor 1268. Regul Toxicol Pharmacol 40(1):42-53; doi: 10.1016/j.yrtph.2004.04.005 .
View Abstract
Publication: Manuscripts
Panko JM , Unice KM, Shay EC, Price P. Childhood exposure assessment of acetone. International Society for Exposure Assessment, 2004.
Publication: Abstracts and Presentations
Gentry PR, Covington TR , Mann S, Shipp AM, Yager JW, Clewell HJ III. 2004. Physiologically based pharmacokinetic modeling of arsenic in the mouse. J Toxicol Environ Health A 67:43–71.
View Abstract
Publication: Manuscripts
Proctor DM , Panko JM , Liebig EW, Paustenbach DJ. 2004. Estimating historical occupational exposure to airborne hexavalent chromium in a chromate production plant: 1940–1972. J Occup Environ Hyg 1(11):752–767; doi: 10.1080/15459620490523294 .
View Abstract
Publication: Manuscripts
Mally A, Zepnik H, Wanek P, Eder E, Dingley K , Ihmels H., et al. 2004. Ochratoxin A: Lack of formation of covalent DNA adducts. Chem Res Toxicol 17(2):234–242; doi: 10.1021/tx034188m . PMID: 14967011.
View Abstract
Publication: Manuscripts
Rogers JM , Brannen KC, Barbee BD, Zucker RM, Degitz SJ. 2004. Maternal methanol exposure during gastrulation causes holoprosencephaly, facial dysgenesis and cervical vertebral malformations in C57BL/6J mice. Birth Defects Res B 71(2):80-88; doi: 10.1002/bdrb.20003 .
View Abstract
Publication: Manuscripts
Degitz SJ, Rogers JM , Zucker RM, Hunter ES III. 2004. Developmental toxicity of methanol: Pathogenesis in CD-1 and C57BL/6J mice exposed in whole embryo culture. Birth Defects Res A 70(4):179–184; doi: 10.1002/bdra.20009 .
View Abstract
Publication: Manuscripts
Degitz SJ, Zucker RM, Kawanishi CY, Massenburg GS, Rogers JM. 2004. Pathogenesis of methanol-induced craniofacial defects in C57BL/6J mice. Birth Defects Res A 70(4):172–178; doi: 10.1002/bdra.20010 .
View Abstract
Publication: Manuscripts
Slikker W Jr., Andersen ME, Bogdanffy MS, Bus JS, Cohen SD, Conolly RB, David RM, Doerrer NG, Dorman DC, Gaylor DW, Hattis D, Rogers JM , Setzer RW, Swenberg JA, Wallace K. 2004. Dose-dependent transitions in mechanisms of toxicity. Toxicol Appl Pharmacol 201(3):203–225; doi:10.1016/j.taap.2004.06.019 .
View Abstract
Publication: Manuscripts
Clewell HJ, Gentry PR, Covington TR , Sarangapani R, Teeguarden JG. 2004. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol Sci 79(2):381–93.
View Abstract
Publication: Manuscripts
Staskal DF , Diliberto JJ, DeVito MJ, Birnbaum LS. Disposition of 2,2’,4,4’-tetrabromodiphenylether (BDE 47) in female mice. Society for Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.
Publication: Abstracts and Presentations
Lau C, JL Butenhoff, JM Rogers. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198(2):231-241; doi: 10.1016/j.taap.2003.11.031 .
View Abstract
Publication: Manuscripts
Hardick J, Gaydos CA, Wagner M , Hardick A, Wood BJ, Miller M. High prevalence of trichomonas vaginalis among women who use drugs in New York City. National STD Prevention Conference, Philadelphia, PA, 2004.